Invesco Ltd. Sorrento Therapeutics, Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.74 - $1.83 $20,698 - $51,186
27,971 Added 22.92%
149,982 $133,000
Q3 2022

Nov 14, 2022
BUY
$1.51 - $2.88 $5,313 - $10,134
3,519 Added 2.97%
122,011 $192,000
Q2 2022

Aug 15, 2022
SELL
$1.24 - $2.33 $5,829 - $10,953
-4,701 Reduced 3.82%
118,492 $238,000
Q1 2022

May 16, 2022
SELL
$2.0 - $4.9 $9,620 - $23,569
-4,810 Reduced 3.76%
123,193 $287,000
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.23 $35,619 - $55,381
7,660 Added 6.37%
128,003 $596,000
Q3 2021

Nov 15, 2021
BUY
$7.41 - $10.99 $171,482 - $254,330
23,142 Added 23.81%
120,343 $919,000
Q2 2021

Aug 17, 2021
BUY
$6.35 - $10.0 $218,840 - $344,630
34,463 Added 54.93%
97,201 $942,000
Q1 2021

May 17, 2021
SELL
$7.03 - $16.51 $299,267 - $702,830
-42,570 Reduced 40.42%
62,738 $519,000
Q4 2020

Feb 16, 2021
SELL
$5.76 - $11.95 $513,826 - $1.07 Million
-89,206 Reduced 45.86%
105,308 $719,000
Q3 2020

Nov 16, 2020
SELL
$6.17 - $18.82 $9.6 Million - $29.3 Million
-1,555,220 Reduced 88.88%
194,514 $2.17 Million
Q2 2020

Aug 14, 2020
BUY
$1.73 - $6.76 $2.89 Million - $11.3 Million
1,667,976 Added 2040.14%
1,749,734 $11 Million
Q1 2020

May 15, 2020
SELL
$1.57 - $4.76 $18,690 - $56,667
-11,905 Reduced 12.71%
81,758 $150,000
Q4 2019

Feb 14, 2020
SELL
$1.45 - $4.17 $8,988 - $25,849
-6,199 Reduced 6.21%
93,663 $317,000
Q3 2019

Nov 14, 2019
SELL
$2.05 - $2.69 $8,103 - $10,633
-3,953 Reduced 3.81%
99,862 $214,000
Q2 2019

Aug 14, 2019
SELL
$2.67 - $4.38 $9,539 - $15,649
-3,573 Reduced 3.33%
103,815 $277,000
Q1 2019

May 15, 2019
BUY
$1.86 - $5.94 $199,741 - $637,884
107,388 New
107,388 $510,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email